洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR2600132915】Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial

基本信息
登记号

ChiCTR2600132915

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-09-20

临床申请受理号

/

靶点

/

适应症

Pregnant women

试验通俗题目

Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial

试验专业题目

Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

To assess the feasibility and acceptability of the JoyMUM intervention among pregnant women and to identify potential challenges to inform refinement of the study procedures and intervention content. Additionally, this study aims to explore preliminary changes in stress outcomes and stress-related factors to support the planning of a future definitive trial.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Randomization will be implemented via an online randomization system by a person who is not involved in the study. Randomization will occur only after confirmation of eligibility and informed consent. Eligible participants were randomly assigned to one of two groups in a 1:1 ratio using computer-generated randomization.

盲法

The outcome assessor will be blinded.

试验项目经费来源

Self-funded

试验范围

/

目标入组人数

18

实际入组人数

/

第一例入组时间

2026-09-30

试验终止时间

2027-09-30

是否属于一致性

/

入选标准

Women will be recruited based on the following inclusion criteria: 1.Aged over 18 years; 2.Currently pregnant with a gestation age of 25-29 weeks; 3.Regardless of parity and gravidity; 4.Planning to deliver in Hong Kong; 5.Able to read and write in English, Traditional Chinese, or Simplified Chinese; and 6.Having access to social media (WhatsApp/WeChat/Instagram) and online conference platforms (Zoom/VooV Meeting) with internet access. Women will be recruited based on the following inclusion criteria:1.Aged over 18 years; 2.Currently pregnant with a gestation age of 25-29 weeks; 3.Regardless of parity and gravidity; 4.Planning to deliver in Hong Kong; 5.Able to read and write in English, Traditional Chinese, or Simplified Chinese; and 6.Having access to social media (WhatsApp/WeChat/Instagram) and online conference platforms (Zoom/VooV Meeting) with internet access.;

排除标准

Participants will be excluded if they: 1.Are under 25 weeks’ gestation, due to higher risk of early pregnancy loss and uncertainty about fetal viability, or over 29 weeks’ gestation, when there may be too little time before labour to complete the intervention and follow-up; 2.Carry an abnormal infant; 3.Have complicated medical problems; or 4.Cannot speak or read English, Cantonese, or Mandarin.;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

全球药物研发中心
全球研发数据与行业前沿情报

388,096个
全球在研药物数
4,715个
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源:摩熵医药
更新时间:
研发动态
相关报告
政策法规
更多信息,请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,632亿元
2026年Q2总销售额
6.14%(2026Q2)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入医药市场洞察中心查看